Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,956 DKK | -0.05% | -2.56% | -9.21% |
Apr. 30 | Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer | MT |
Apr. 30 | Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.21% | 18.14B | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B | |
+327.62% | 8.78B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- BTIG Starts Genmab at Buy With $44 Price Target